The short version of synthetic peptide fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-07-02 and is reviewed periodically as new material appears.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
In 1977, Sanger then adopted a primer-extension strategy to develop more rapid DNA sequencing methods at the MRC Centre, Cambridge, UK. This technique was similar to his "Plus and Minus" strategy, however, it was based upon the selective incorporation of chain-terminating dideoxynucleotides (ddNTPs) by DNA polymerase during in vitro DNA replication. Sanger published this method in the same year. Gilbert's interest in DNA sequencing arose from studies of gene regulation, particularly the lac operon. The method represented one of the first practical techniques for rapid DNA sequencing and earned Gilbert and Frederick Sanger the 1980 Nobel Prize in Chemistry for their independent contributions to nucleic acid sequencing.
== Fictional character biography == Thomas A. Anderson was born in Lower Downtown, Capital City, USA on March 11, 1962, according to his criminal record, or September 13, 1971 according to his passport (both seen in the film). His mother was Michelle McGahey (the name of the first film's art director) and his father was John Anderson. He attended Central West Junior High and Owen Patterson High (named after the film's production designer). In high school, he excelled at science, math and computer courses, and displayed an aptitude for literature and history. Although he had disciplinary troubles when he was thirteen to fourteen years old, Anderson went on to become a respected member of the school community through his involvement in football and hockey. At the start of the series, Neo is one of billions of humans neurally connected to the Matrix, unaware that the world he lives in is a simulated reality.
=== 18th century === Developmental bioelectricity began in the 18th century. Several seminal works stimulating muscle contractions using Leyden jars culminated with the publication of classical studies by Luigi Galvani in 1791 (De viribus electricitatis in motu musculari) and 1794. In these, Galvani thought to have uncovered intrinsic electric-producing ability in living tissues or "animal electricity". Alessandro Volta showed that the frog's leg muscle twitching was due to a static electricity generator and from dissimilar metals undergoing or catalyzing electrochemical reactions. Galvani showed, in a 1794 study, twitching without metal electricity by touching the leg muscle with a deviating cut sciatic nerve, definitively demonstrating "animal electricity". Unknowingly, Galvani with this and related experiments discovered the injury current (ion leakage driven by the intact membrane/epithelial potential) and injury potential (potential difference between injured and intact membrane/epithelium). The injury potential was, in fact, the electrical source behind the leg contraction, as realized in the next century. Subsequent work ultimately extended this field broadly beyond nerve and muscle to all cells, from bacteria to non-excitable mammalian cells.
Brown sugars are granulated sugars, either containing residual molasses, or with the grains deliberately coated with molasses to produce a light- or dark-coloured sugar such as muscovado and turbinado. They are used in baked goods, confectionery, and toffees. Their darkness is due to the amount of molasses they contain. They may be classified based on their darkness or country of origin.
6 July – One child dies, while 16 are injured after a Land Rover hits a primary school in Wimbledon, south-west London. The crash is not treated as terror-related, but the driver is arrested on suspicion of causing death by dangerous driving. The UK Health Security Agency and Met Office issue a yellow heat health alert for six regions of England, effective from 12pm on 7 July to 9am on 9 July, when temperatures are expected to reach 28 °C–30 °C in some areas. RMT workers on the London Underground announce six days of strikes from Sunday 23 July to Friday 28 July. 7 July – British cinema chain Empire Cinemas collapses into administration with the immediate loss of 150 jobs, citing the impact of the COVID-19 pandemic and the ongoing cost-of-living crisis as the main reasons. The closures leave Sunderland and Wigan with no main cinema. 8 July – The Union Chain Bridge, which spans the River Tweed, linking England and Scotland, is named as an International Historic Civil Engineering Landmark. 9 July – A second child dies of injuries sustained in the crash at a school in Wimbledon, south London. 10 July – A teenage boy is arrested on suspicion of attempted murder after a teacher is stabbed at Tewkesbury School in Gloucestershire. The school, along with neighbouring schools, are locked down during the incident. The teacher is hospitalised. He is charged with attempted wounding with intent and possession of bladed article the next day.
Sources: en.wikipedia.org
=== Fiber-optic SPR === Recent advancements in SPR technology have given rise to novel formats, increasing the scope and applicability of SPR sensing. Fiber optic SPR involves the integration of SPR sensors into the optical fibers, enabling the direct coupling of light with the surface plasmons as light is passed through the hollow SPR core, and the analyte is behind a thin metal sheet surrounding the hollow core. This format offers enhanced sensitivity and allows for the development of compact sensing devices, making it particularly valuable for applications requiring remote sensing in the field. It also offers an increased surface area for analytes to bind to the inner lining of the fiber optic.
== History and ideology == The RF was founded on 13 March 1962 in a merger of the Dominion Party (DP), defectors from the anti-Whitehead faction of the United Federal Party (UFP) and former members of the Southern Rhodesia Liberal Party. It was shaky and ideologically split in its early days, with its heterogeneous membership (ranging from advocates of more gradual transition to explicit segregation) united only in their opposition to then-Prime Minister Edgar Whitehead's plans for transition to majority rule, as well as the UK's demands for majority rule before independence. The party harnessed white anxieties of a Congo and Kenya-style majority rule scenario in its successful campaign for the 1962 Southern Rhodesian general election, pledging to keep power "in responsible hands", ensure Southern Rhodesian independence from the Federation, and thwart "this mad idea of a hand-over, of a sell-out of the European and his civilisation, indeed of everything he had put into his country". Its opposition to the UK government's demands for majority rule was so great that the RF-led government eventually declared unilateral independence in 1965. The RF had fifteen founding principles, which included the preservation of each racial group's right to maintain its own identity, the preservation of "proper standards" through meritocracy, the maintenance of the Land Apportionment Act, which formalised the racial imbalance in the ownership and distribution of land, opposition to compulsory racial integration, job protection for white workers, and the practice of Christianity.
== Development and patents == D-Ribose-L-cysteine was developed by Herbert T. Nagasawa, a medicinal chemist formerly affiliated with the United States Department of Veterans Affairs and the University of Minnesota, whose research focused on sulfur amino acid metabolism and hepatic toxicology. The compound and its use as a glutathione-enhancing agent are protected by multiple patents, including United States Patent US 9,173,917 B2, assigned to Max International and the U.S. Department of Veterans Affairs. D-Ribose-L-cysteine has since been incorporated into dietary supplement formulations marketed by Max International, Inc. and LiveMax, LLC.
However, at least one court case has resulted in a product being taken off the market. In December 2010, the United States Food and Drug Administration (FDA) issued a warning to consumers about such products stating, "The FDA has found many products marketed as dietary supplements for sexual enhancement during the past several years that can be harmful because they contain active ingredients in FDA-approved drugs or variations of these ingredients."
=== Other African countries === Nando's has been operating in Botswana since 1993. There are 19 restaurants in Botswana; 10 in Gaborone, two in Francistown and Palapye, and one each in Jwaneng, Maun, Mahalapye, Kasane and Letlhakane. There are four outlets in Eswatini; in Mbabane, Matsapha, Ezulwini and Manzini (2022). There are six Nando's restaurant outlets in Mauritius, in Curepipe, Grand-Baie, Moka, Riche Terre, Cascavelle and Vacoas-Phoenix. Nando's began operating in Zambia in 2002. As of August 2021, Nando's has nine restaurants in Zambia; seven in Lusaka and one each in Ndola and Kitwe. Nando's has been operating in Zimbabwe since 1995. As of August 2021, Nando's has 14 restaurants in Zimbabwe; nine in Harare and one each in Bulawayo, Mutare, Gweru, Kwekwe and Victoria Falls.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.